Precision BioSciences Reports First Quarter 2020 Financial Results and Provides Business Update

NEXT STORY
Surface Oncology to Present Preclinical Data for Multiple Product Programs at the American Association for Cancer Research Annual Meeting
PREV STORY
MediPharm Labs Australia Signs First European White-Label Cannabis Supply Agreement With UK-Based Cannaray’s Therismos
Subscribe to PM360
Print Subscription

Experts on Call

Follow Us
Get in touch with PM360 Experts On Call

Ads

You May Also Like

Hemispherx Updates Stockholders, Highlighting Ampligen’s Role in Enhancing Immunotherapeutic Therapies

OCALA, Fla., Aug. 13, 2018 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American: HEB), ...

author_avatar
NASDAQ Market News

ChemioCare Strengthens Executive Management Team

NEW YORK, Jan. 07, 2019 (GLOBE NEWSWIRE) -- ChemioCare USA Inc. (“ChemioCare” or the ...

author_avatar
NASDAQ Market News

Roche to present five-year OCREVUS (ocrelizumab) efficacy and safety data in relapsing and primary progressive multiple sclerosis (MS) at ECTRIMS

Data reinforce importance of early initiation and continuation of OCREVUS treatment New analyses highlight ...

author_avatar
NASDAQ Market News